News
It’s amazing how many ways you can send money to your friends. I still remember when PayPal PYPL was the only way, but nowadays,...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Monte Independent Investment Research: Michael Del Monte is a buy-side equity analyst with over 5 years of industry...
News
This article was written by Follow Wasatch Global Investors is a 100% employee-owned investment manager founded in 1975 and headquartered in Salt Lake City,...
News
This article was written by Follow Lazard Asset Management delivers world-class investment solutions and long-term value for their clients. When clients partner with Lazard,...
News
Ardmore Shipping Corporation (NYSE:ASC) recently noted a transformation phase that included the optimization of the schedules of its ships and the reduction in fuel...
News
A few weeks ago, I wrote a cautious article on the Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust (GBAB), arguing investors should...
News
What businesses underpin our world? What businesses make a compelling case for investment? Depending on who you ask, everyone has a different answer. The...
News
Soft landing? Not so fast. The triple threat of rising interest rates, oil prices, and the US dollar is the result of the ubiquitous...
News
BTI and Ray Dalio’s grand scheme of investing The goals of this article are twofold. First, I want to share the key insights I’ve...
News
Medical Equipment is a large market where disruptive technology that provides lower costs creates competition and progress. Nano-X Imaging Ltd. (NASDAQ:NNOX) is a company...
News
For the first time in several months, I’m seeing some bargains beginning to appear in the market. Of course, I’m more conservative with purchases...
News
Written by Nick Ackerman. Real estate investment trusts (“REITs”) have been getting hit hard by higher yields as the Fed ramped up interest rates....
News
Reason for the update: New clinical data readout The most recent clinical data from NewAmsterdam Pharma (NASDAQ:NAMS) has showcased the potential of obicetrapib in...
